Enzalutamide inhibits proliferation of gemcitabine-resistant bladder cancer cells with increased androgen receptor expression

Koji Kameyama(Gifu University), Masafumi Ito(Tokyo Metropolitan Institute of Gerontology)
International Journal of Oncology
November 24, 2016
Cited by 26


Related Papers